Skip to main content
56°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
110.86
+1.28 (+1.17%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novartis AG Common Stock
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
44
45
Next >
Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands
September 22, 2022
Via
Benzinga
Top Financial Media Stories Wednesday, September 21: Amazon's Roomba Maker Acquisition Attracts Regulatory Attention, Binance And FTX Bid For Voyager Digital's Assets, Germany Nationalizes Gas Giant Uniper To Avert Energy Crisis And More..
September 21, 2022
Wall Street Journal
Via
Benzinga
Novartis To Petition US Supreme Court To Uphold Patent Validity For Multiple Sclerosis Drug, Gilenya
September 21, 2022
Via
Benzinga
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
September 20, 2022
Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology.
Via
InvestorPlace
Novartis' Cosentyx Shows To Ease Symptoms In Painful Skin Condition
September 12, 2022
Via
Benzinga
Novartis Injects $300M In Early-Stage Biologics Research Tech
September 12, 2022
Via
Benzinga
Novartis' Kisqali Adds One More Year Of Survival Benefit In Breast Cancer Setting
September 09, 2022
Via
Benzinga
Vasculitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, Ambulero, InflaRx
September 19, 2022
Continue reading "Vasculitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, Ambulero, InflaRx"
Via
Get News
5 Value Stocks In The Healthcare Sector
September 19, 2022
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
Top Financial Media Stories Thursday, September 15: US Railway Companies, Unions Reach Tentative Agreement, Tesla To Wind Down Stores In China's Flashy Malls, Netflix Could Face Legal Action Over South Korean Crime Drama And More..
September 15, 2022
US Railway Companies, Unions Reach Tentative Agreement Averting Catastrophic Strike
Via
Benzinga
Swiss Competition Commission Investigates Novartis' Patent Use To Fend Off Competition
September 15, 2022
The Swiss competition commission (COMCO) has initiated an investigation against Novartis AG (NYSE: NVS) over the alleged unlawful patent use to reduce competitive pressure.
Via
Benzinga
VideoKrtoon Offers State Of The Art 2D Animation Services
September 07, 2022
Via
Prodigy
Novartis To Spinoff Sandoz Business To Create #1 European Generics Company
August 25, 2022
Via
Benzinga
Novartis Dodges Whistleblower Lawsuit Regarding Multiple Sclerosis Drug Kickback Claims
September 14, 2022
A federal judge dismissed a whistleblower lawsuit accusing Novartis AG (NYSE: NVS) of paying doctors kickbacks at "sham" speaker programs to boost prescriptions of its multiple sclerosis blockbuster...
Via
Benzinga
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
September 13, 2022
Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati
Via
Benzinga
5 Value Stocks In The Healthcare Sector
September 12, 2022
What are Value Stocks?
Via
Benzinga
Smart Manufacturing Market Share 2022 Size, Key Trends, Future Scope, Global Outlook, Investment Plans and Development Status by 2027
September 09, 2022
Smart Manufacturing Market 2022 | Major Key Players included in this Report are Pfizer , Novartis, Abbott Laboratories and Many More with SWOT Analysis by 2027
Via
SBWire
No Early Relief for JW Therapeutics from Cancer Wonder Drug
September 07, 2022
Key Takeaways: JW Therapeutics prices its new cancer therapy at around a million yuan, with the high production costs hard to bring down. Large-scale market expansion is not going to be easy The...
Via
Benzinga
Appointment of Sachin Nanavati to PreveCeutical's Board of Directors
September 06, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...
Via
Newsfile
SiO2 Materials Science Names Yves Steffen as Chief Executive Officer
September 01, 2022
SiO2 Materials Science today announced the Board of Directors has appointed Yves Steffen as CEO effective Aug. 1, 2022.
Via
Newswire.com
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
September 01, 2022
Wall Street Journal
Via
Benzinga
Novartis Appoints Merck Executive As Research Head
September 01, 2022
Via
Benzinga
NYSE:NVS Investor Alert: Investigation over Potential Wrongdoing at Novartis AG
August 30, 2022
San Diego, CA -- (SBWIRE) -- 08/30/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Novartis AG.
Via
SBWire
Novartis' Scemblix Snags European Approval For Chronic Myeloid Leukemia
August 29, 2022
Via
Benzinga
With Sandoz Spinoff, Novartis Slams Brakes On Huntington's Trial
August 25, 2022
Novartis AG (NYSE: NVS) suspended dosing in a Huntington's disease study because early signs of side effects were seen in some participants in the trial.
Via
Benzinga
Benzinga Before The Bell: Twitter Whistleblower Peiter Zatko To Depose Before Senate Panel, GameStop To Boost Employee Compensation To Drive Growth, California Proposes Total Ban On New Gasoline Car Sales By 2035 And Other Top Financial Stories Thursday,
August 25, 2022
Reuters Stuck By Chip Shortage, Stellantis Halts Production In Sochaux Plant
Via
Benzinga
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
August 23, 2022
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of
Via
Spotlight Growth
Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
August 18, 2022
Via
Benzinga
Emery Pharma Announces New Biologics Analytical Division
August 17, 2022
Supporting end-to-end research and development of large molecule drugs including, biologics, antibody-drug conjugates, biosimilars, and more
Via
Newswire.com
A Look Into Healthcare Sector Value Stocks
August 15, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...
Via
Benzinga
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
44
45
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.